Clinical trial
NGS Strategy Effectiveness in Molecular Diagnosis
NCT03557567 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NGS Strategy Effectiveness in Molecular Diagnosis
- Lead sponsor
- Istituto Ortopedico Rizzoli
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 29, 2014
- Completion date
- September 30, 2017
- Enrollment
- 400 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
multiple osteochondroma, osteogenesis imperfecta